Literature DB >> 17643902

Non-achalasic motor disorders of the oesophagus.

Daniel Sifrim1, Fernando Fornari.   

Abstract

Motor abnormalities of the oesophagus are characterised by a chronic impairment of the neuromuscular structures that co-ordinate oesophageal function. The best-defined entity is achalasia, which is discussed in a separate chapter. Other motor disorders with clinical relevance include diffuse oesophageal spasm, oesophageal dysmotility associated with scleroderma, and ineffective oesophageal motility. These non-achalasic motor disorders have variable prevalence but they could be associated with invalidating symptoms such as dysphagia, chest pain and gastro-oesophageal reflux disease. New oesophageal diagnostic techniques, including high-resolution manometry, high-frequency intraluminal ultrasound and intraluminal impedance, allow (1) better definition of peristalsis and sphincter function, (2) assessment of changes in oesophageal wall thickness, and (3) evaluation of pressure gradients within the oesophagus and across the sphincters that can produce normal or abnormal patterns of bolus transport. This chapter discusses recent advances in physiology, pathophysiology, diagnosis and treatment of non-achalasic oesophageal motor disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17643902     DOI: 10.1016/j.bpg.2007.03.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  6 in total

1.  Etiological spectrum of motor dysphagia as per Chicago Classification--Experience at a tertiary center in Central India.

Authors:  Mayank Jain; Sandip Ware; Amit Bundiwal; Shohini Sircar; Ajay K Jain
Journal:  Indian J Gastroenterol       Date:  2015-03

2.  Buspirone, a new drug for the management of patients with ineffective esophageal motility?

Authors:  Charlotte Scheerens; Jan Tack; Nathalie Rommel
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

3.  Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study.

Authors:  George P Karamanolis; Stylianos Panopoulos; Anastasios Karlaftis; Konstantinos Denaxas; Dimitrios Kamberoglou; Petros P Sfikakis; Spiros D Ladas
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

4.  Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

Authors:  Mohammad Bashashati; Reza A Hejazi; Christopher N Andrews; Martin A Storr
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04-09

5.  A case of symptomatic diffuse esophageal spasm during multiple rapid swallowing test on high-resolution manometry.

Authors:  Eun Mi Lee; Moo In Park; Won Moon; Kyung Mi Kim; Seun Ja Park; Hyung Hun Kim
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

6.  A patient with progression of diffuse esophageal spasm to classic achalasia.

Authors:  Seon Young Park; Jong Sun Rew
Journal:  J Neurogastroenterol Motil       Date:  2012-01-16       Impact factor: 4.924

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.